61084 Federal Register / Vol. 79, No. 196 / Thursday, October 9, 2014 / Notices 

SUMMARY: The Food and Drug 

Administration (FDA) is requesting 

nominations for voting members to 

serve on the Tobacco Products Scientific 

Advisory Committee, Office of Science, 

Center for Tobacco Products. 

FDA seeks to include the views of 

women and men, members of all racial 

and ethnic groups, and individuals with 

and without disabilities on its advisory 

committees and, therefore, encourages 

nominations of appropriately qualified 

candidates from these groups. 

DATES: Nominations received on or 

before December 8, 2014 will be given 

first consideration for membership on 

the Tobacco Products Scientific 

Advisory Committee. Nominations 

received after December 8, 2014 will be 

considered for nomination to the 

committee as later vacancies occur. 

ADDRESSES: All nominations for 

membership should be submitted 

electronically by logging into the FDA 

Advisory Committee Membership 

Nomination Portal: https:// 

www.accessdata.fda.gov/scripts/ 

FACTRSPortal/FACTRS/index.cfm, by 

mail to Advisory Committee Oversight 

and Management Staff, Food and Drug 

Administration 10903 New Hampshire 

Ave., Bldg. 32, rm. 5103, Silver Spring, 

MD 20993–0002, or by FAX to 301–847– 

8640. 

Information about becoming a 

member on an FDA advisory committee 

can also be obtained by visiting FDA’s 

Web site at: http://www.fda.gov/ 

AdvisoryCommittees/default.htm. 

FOR FURTHER INFORMATION CONTACT: 

Regarding all nomination questions for 

membership, the primary contact is: 

Caryn Cohen, Office of Science, Center 

for Tobacco Products, Center for 

Tobacco Products Document Control 

Center, Food and Drug Administration, 

10903 New Hampshire Avenue, Bldg. 

71, rm. G335, Silver Spring, MD 20993– 

0002, 1–877–287–1373 (choose Option 

5), FAX: 240–276–3655, email: 

TPSAC@fda.hhs.gov.: 

SUPPLEMENTARY INFORMATION: FDA is 

requesting nominations for voting 

members on the Tobacco Products 

Scientific Advisory Committee. 

I. General Description of the Committee 

Duties 

The Tobacco Products Scientific 

Advisory Committee (the Committee) 

advises the Commissioner of Food and 

Drugs (the Commissioner) or designee in 

discharging responsibilities related to 

the regulation of tobacco products. The 

Committee reviews and evaluates safety, 

dependence, and health issues relating 

to tobacco products and provides 

appropriate advice, information, and 

recommendations to the Commissioner. 

II. Criteria for Voting Members 

The Committee consists of 12 

members including the Chair. Members 

and the Chair are selected by the 

Commissioner or designee from among 

individuals knowledgeable in the fields 

of medicine, medical ethics, science, or 

technology involving the manufacture, 

evaluation, or use of tobacco products. 

Members are invited to serve for 

overlapping terms of up to 4 years. 

Almost all non-Federal members of this 

committee serve as Special Government 

Employees. The Committee includes 

nine technically qualified voting 

members, selected by the Commissioner 

or designee. The nine voting members 

include seven members who are 

physicians, dentists, scientists, or health 

care professionals practicing in the area 

of oncology, pulmonology, cardiology, 

toxicology, pharmacology, addiction, or 

any other relevant specialty. The nine 

voting members also include one 

member who is an officer or employee 

of a state or local government or of the 

Federal Government, and one member 

who is a representative of the general 

public. 

In addition to the voting members, the 

Committee includes three nonvoting 

members who are identified with 

industry interests. These members 

include one representative of the 

interests of the tobacco manufacturing 

industry, one representative of the 

interests of tobacco growers, and one 

representative of the interests of the 

small business tobacco manufacturing 

industry, which position may be filled 

on a rotating, sequential basis by 

representatives of different small 

business tobacco manufacturers based 

on areas of expertise relevant to the 

topics being considered by the 

Committee. 

III. Nomination Procedures 

Any interested person may nominate 

one or more qualified individuals for 

membership on the Committee. Selfnominations are also accepted. 

Nominations must include a current, 

complete re ́sume ́ or curriculum vitae for 

each nominee, including current 

business address and/or home address, 

telephone number, and email address if 

available. Nominations must also 

specify the advisory committee for 

which the nominee is recommended. 

Nominations must also acknowledge 

that the nominee is aware of the 

nomination unless self-nominated. FDA 

will ask potential candidates to provide 

detailed information concerning such 

matters as financial holdings, 

employment, and research grants and/or 

contracts to permit evaluation of 

possible sources of conflicts of interest. 

This notice is issued under the 

Federal Advisory Committee Act (5 

U.S.C. app. 2) and 21 CFR part 14, 

relating to advisory committees. 

Dated: October 3, 2014. 

Jill Hartzler Warner, 

Associate Commissioner for Special Medical 

Programs. 

[FR Doc. 2014–24074 Filed 10–8–14; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Policy on Conferring With Urban Indian 

Organizations; Correction 

AGENCY: Indian Health Service, HHS. 

ACTION: Notice; correction. 

SUMMARY: The Indian Health Service is 

issuing this Notice to correct the 

effective date from October 29, 2014 to 

September 22, 2014 for the final Policy 

for Conferring with Urban Indian 

Organizations. The notice published at 

79 FR 58359, September 29, 2014. 

FOR FURTHER INFORMATION CONTACT: 

Office of Management Services, 

Management Policy and Internal Control 

Staff, Indian Health Service, 801 

Thompson Avenue, Suite 625A, 

Rockville, MD 20852, Telephone (301) 

443–2650. (This is not a toll-free 

number.) 

Correction 

In the Federal Register of September 

29, 2014, in FR Doc. 2014–23005, on 

page 58359, in the third column, 

following DATES the correct date should 

read as follows: 

This Policy is effective September 22, 

2014. 

Dated: October 3, 2014. 

Yvette Roubideaux, 

Acting Director, Indian Health Service. 

[FR Doc. 2014–24154 Filed 10–8–14; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 79, No. 196 / Thursday, October 9, 2014 / Notices 61085 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Time Sensitive 

Obesity Policy Reviews. 

Date: October 23, 2014. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Michele L. Barnard, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 753, 6707 Democracy Boulevard, 

Bethesda, MD 20892–2542, (301) 594–8898, 

barnardm@extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: October 1, 2014. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–24058 Filed 10–8–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Arthritis and 

Musculoskeletal and Skin Diseases Initial 

Review Group; Arthritis and Musculoskeletal 

and Skin Diseases Special Grants Review 

Committee. 

Date: October 30–31, 2014. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Helen Lin, Ph.D., 

Scientific Review Officer, NIH/NIAMS/RB, 

6701 Democracy Blvd., Suite 800, Plaza One, 

Bethesda, MD 20817, 301–594–4952, linh1@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS). 

Dated: October 3, 2014. 

Carolyn Baum, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–24064 Filed 10–8–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel. 

Date: November 5, 2014. 

Time: 10:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Peter Zelazowski, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, NIH, 6100 Executive 

Boulevard, Rm. 5B01, Bethesda, MD 20892– 

7510, 301–435–6902, peter.zelazowski@

nih.gov. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; ‘‘Shoulder 

Pathology’’. 

Date: November 7, 2014. 

Time: 2:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Joanna Kubler-Kielb, 

Scientific Review Officer, Scientific Review 

Branch, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, 6100 Executive Boulevard, 

Room 5B01, Bethesda, MD 20892–7510, 301– 

435–6916, kielbj@mail.nih.gov. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; In-vivo methods for 

assessing placental development and 

function. 

Date: November 12, 2014. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Sathasiva B. Kandasamy, 

Ph.D., Scientific Review Administrator, 

Scientific Review Branch, National Institute 

of Child Health and Human Development, 

6100 Executive Boulevard, Room 5B01, 

Bethesda, MD 20892–9304, (301) 435–6680, 

skandasa@mail.nih.gov. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Educational 

Programs. 

Date: November 14, 2014. 

Time: 8:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Washington, 1515 

Rhode Island Ave NW., Washington, DC 

20005. 

Contact Person: Carla T. Walls, Ph.D., 

Scientific Review Administrator, Scientific 

Review Branch, National Institute of Child 

Health and Human Development, NIH, 6100 

Executive Blvd., Room 5B01, Bethesda, MD 

20892, 301–435–6898, wallsc@mail.nih.gov. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel. 

Date: November 20–21, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road NW., 

Washington, DC 20015. 

Contact Person: Cathy J. Wedeen, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, NIH, DHHS, 6100 Executive 

Blvd., Room 5B01–G, Bethesda, MD 20892, 

301–435–6878, wedeenc@mail.nih.gov. 

mstockstill on DSK4VPTVN1PROD with NOTICES